Review



fitc lta  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Vector Laboratories fitc lta
    Fitc Lta, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 557 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fitc+lta/pmc12784183-114-29-31?v=Vector+Laboratories
    Average 96 stars, based on 557 article reviews
    fitc lta - by Bioz Stars, 2026-07
    96/100 stars

    Images



    Similar Products

    96
    Vector Laboratories fitc lta
    Fitc Lta, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fitc+lta/pmc12784183-114-29-31?v=Vector+Laboratories
    Average 96 stars, based on 1 article reviews
    fitc lta - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Vector Laboratories fitc conjugated lotus tetragonolobus agglutinin lta
    Fitc Conjugated Lotus Tetragonolobus Agglutinin Lta, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fitc+lta/pm35862648-69-0-8?v=Vector+Laboratories
    Average 96 stars, based on 1 article reviews
    fitc conjugated lotus tetragonolobus agglutinin lta - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Vector Laboratories lta fitc
    Lta Fitc, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fitc+lta/pm32840752-48-8-9?v=Vector+Laboratories
    Average 96 stars, based on 1 article reviews
    lta fitc - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    94
    Novus Biologicals mouse monoclonal fitc anti lta antibody
    ( A-C ) Molecular docking of KAMP-10 and KAMP-18C (ribbon representation) to TLRs and their co-receptors (ribbon and surface representations). Top five models of the peptides (1 to 5: yellow, green, red, magenta, cyan) docked to the receptors are shown. (A) KAMP-10 was predicted to bind to the hydrophobic cavity of MD-2 that is in complex with TLR4 (top) or in the soluble form (bottom). (B-C) KAMP-18C was predicted to bind to hydrophobic pocket at the central domain of TLR2 (B) and at the N-terminal domain of CD14 (C). ( D ) Representative FACS plots (left) and quantification (right) showing the extent of LPS binding to TLR4/MD-2-conjugated beads. Latex beads with human TLR4-MD-2 complex conjugated on the surface were incubated with the peptides (KAMP-10 or SC-10 at 48 μg/ml, or KAMP-18C at 96 μg/ml) in the absence or presence of soluble MD-2 (1 μg/ml), washed, then incubated with <t>FITC-LPS</t> (1 μg/ml). Bead surface TLR4 was labeled with antibody followed by flow cytometry. Percent of TLR4-MD-2 + beads that were FITC-LPS + is shown. ( E-F ) Representative FACS plots (top) and quantification (bottom) showing the extent of <t>LTA</t> binding to TLR2-conjugated beads. (E) Human TLR2-conjugated beads were incubated with the peptides (48 or 96 μg/ml), washed, then incubated with LTA (1 μg/ml) and CD14 (0.1 μM). (F) CD14 (0.1 μM) was preincubated with equal molar of peptides (0.1 μM) before TLR2-conjugated beads and LTA (1 μg/ml) were added. In comparison, KAMP-10 alone (0.1 μM) was preincubated with TLR2-conjugated beads, followed by bead washing then incubation with LTA (1 μg/ml) and CD14 (0.1 μM). TLR2 and LTA were labeled with antibody for flow cytometric analysis. Percent of TLR2 + beads that were FITC-LTA + is shown. Mean (n=3 replicates) ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 (ANOVA with Dunnett’s post hoc test).
    Mouse Monoclonal Fitc Anti Lta Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fitc+lta/bio_rxiv__2021__01__18__427180-226-96-103?v=Novus+Biologicals
    Average 94 stars, based on 1 article reviews
    mouse monoclonal fitc anti lta antibody - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    86
    Vector Laboratories lotus tetragonolobus agglutinin lta fitc
    ( A-C ) Molecular docking of KAMP-10 and KAMP-18C (ribbon representation) to TLRs and their co-receptors (ribbon and surface representations). Top five models of the peptides (1 to 5: yellow, green, red, magenta, cyan) docked to the receptors are shown. (A) KAMP-10 was predicted to bind to the hydrophobic cavity of MD-2 that is in complex with TLR4 (top) or in the soluble form (bottom). (B-C) KAMP-18C was predicted to bind to hydrophobic pocket at the central domain of TLR2 (B) and at the N-terminal domain of CD14 (C). ( D ) Representative FACS plots (left) and quantification (right) showing the extent of LPS binding to TLR4/MD-2-conjugated beads. Latex beads with human TLR4-MD-2 complex conjugated on the surface were incubated with the peptides (KAMP-10 or SC-10 at 48 μg/ml, or KAMP-18C at 96 μg/ml) in the absence or presence of soluble MD-2 (1 μg/ml), washed, then incubated with <t>FITC-LPS</t> (1 μg/ml). Bead surface TLR4 was labeled with antibody followed by flow cytometry. Percent of TLR4-MD-2 + beads that were FITC-LPS + is shown. ( E-F ) Representative FACS plots (top) and quantification (bottom) showing the extent of <t>LTA</t> binding to TLR2-conjugated beads. (E) Human TLR2-conjugated beads were incubated with the peptides (48 or 96 μg/ml), washed, then incubated with LTA (1 μg/ml) and CD14 (0.1 μM). (F) CD14 (0.1 μM) was preincubated with equal molar of peptides (0.1 μM) before TLR2-conjugated beads and LTA (1 μg/ml) were added. In comparison, KAMP-10 alone (0.1 μM) was preincubated with TLR2-conjugated beads, followed by bead washing then incubation with LTA (1 μg/ml) and CD14 (0.1 μM). TLR2 and LTA were labeled with antibody for flow cytometric analysis. Percent of TLR2 + beads that were FITC-LTA + is shown. Mean (n=3 replicates) ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 (ANOVA with Dunnett’s post hoc test).
    Lotus Tetragonolobus Agglutinin Lta Fitc, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fitc+lta/10__1681_slash_asn__2020040511-114-6-16?v=Vector+Laboratories
    Average 86 stars, based on 1 article reviews
    lotus tetragonolobus agglutinin lta fitc - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Vector Laboratories lectins lta fitc
    Kidney histology and differential lectin staining. Formalin fixed, paraffin embedded 5 μm sections of kidney tissues from 6 week-old mice of the indicated genotypes were stained with H&E and examined by light microscopy ( A-F ) or stained with <t>lectins</t> <t>LTA</t> (green, proximal tubules) and DBA (red, distal tubules) and examined by immunofluorescence microscopy ( G,H,I ). Panels A-C are 5X magnification with scale bars equal to 100 μm. Boxed areas are shown at 40X magnification in corresponding panels D-F with scale bars equal to 20 μm. Lectin staining was performed on serial sections corresponding to H&E stained samples. Cell nuclei were stained with DAPI. Scale bars in panels G-I are equal to 10 μm. The asterisk (*) identifies a large cyst that was not stained by either LTA or DBA. Images are representative of tissue sections from 3 animals.
    Lectins Lta Fitc, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fitc+lta/bio_rxiv__2020__02__18__946285-105-0-11?v=Vector+Laboratories
    Average 86 stars, based on 1 article reviews
    lectins lta fitc - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    Image Search Results


    ( A-C ) Molecular docking of KAMP-10 and KAMP-18C (ribbon representation) to TLRs and their co-receptors (ribbon and surface representations). Top five models of the peptides (1 to 5: yellow, green, red, magenta, cyan) docked to the receptors are shown. (A) KAMP-10 was predicted to bind to the hydrophobic cavity of MD-2 that is in complex with TLR4 (top) or in the soluble form (bottom). (B-C) KAMP-18C was predicted to bind to hydrophobic pocket at the central domain of TLR2 (B) and at the N-terminal domain of CD14 (C). ( D ) Representative FACS plots (left) and quantification (right) showing the extent of LPS binding to TLR4/MD-2-conjugated beads. Latex beads with human TLR4-MD-2 complex conjugated on the surface were incubated with the peptides (KAMP-10 or SC-10 at 48 μg/ml, or KAMP-18C at 96 μg/ml) in the absence or presence of soluble MD-2 (1 μg/ml), washed, then incubated with FITC-LPS (1 μg/ml). Bead surface TLR4 was labeled with antibody followed by flow cytometry. Percent of TLR4-MD-2 + beads that were FITC-LPS + is shown. ( E-F ) Representative FACS plots (top) and quantification (bottom) showing the extent of LTA binding to TLR2-conjugated beads. (E) Human TLR2-conjugated beads were incubated with the peptides (48 or 96 μg/ml), washed, then incubated with LTA (1 μg/ml) and CD14 (0.1 μM). (F) CD14 (0.1 μM) was preincubated with equal molar of peptides (0.1 μM) before TLR2-conjugated beads and LTA (1 μg/ml) were added. In comparison, KAMP-10 alone (0.1 μM) was preincubated with TLR2-conjugated beads, followed by bead washing then incubation with LTA (1 μg/ml) and CD14 (0.1 μM). TLR2 and LTA were labeled with antibody for flow cytometric analysis. Percent of TLR2 + beads that were FITC-LTA + is shown. Mean (n=3 replicates) ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 (ANOVA with Dunnett’s post hoc test).

    Journal: bioRxiv

    Article Title: Simultaneous Control of Infection and Inflammation by Keratin-Derived Antibacterial Peptides (KAMPs) Targeting TLRs and Co-Receptors

    doi: 10.1101/2021.01.18.427180

    Figure Lengend Snippet: ( A-C ) Molecular docking of KAMP-10 and KAMP-18C (ribbon representation) to TLRs and their co-receptors (ribbon and surface representations). Top five models of the peptides (1 to 5: yellow, green, red, magenta, cyan) docked to the receptors are shown. (A) KAMP-10 was predicted to bind to the hydrophobic cavity of MD-2 that is in complex with TLR4 (top) or in the soluble form (bottom). (B-C) KAMP-18C was predicted to bind to hydrophobic pocket at the central domain of TLR2 (B) and at the N-terminal domain of CD14 (C). ( D ) Representative FACS plots (left) and quantification (right) showing the extent of LPS binding to TLR4/MD-2-conjugated beads. Latex beads with human TLR4-MD-2 complex conjugated on the surface were incubated with the peptides (KAMP-10 or SC-10 at 48 μg/ml, or KAMP-18C at 96 μg/ml) in the absence or presence of soluble MD-2 (1 μg/ml), washed, then incubated with FITC-LPS (1 μg/ml). Bead surface TLR4 was labeled with antibody followed by flow cytometry. Percent of TLR4-MD-2 + beads that were FITC-LPS + is shown. ( E-F ) Representative FACS plots (top) and quantification (bottom) showing the extent of LTA binding to TLR2-conjugated beads. (E) Human TLR2-conjugated beads were incubated with the peptides (48 or 96 μg/ml), washed, then incubated with LTA (1 μg/ml) and CD14 (0.1 μM). (F) CD14 (0.1 μM) was preincubated with equal molar of peptides (0.1 μM) before TLR2-conjugated beads and LTA (1 μg/ml) were added. In comparison, KAMP-10 alone (0.1 μM) was preincubated with TLR2-conjugated beads, followed by bead washing then incubation with LTA (1 μg/ml) and CD14 (0.1 μM). TLR2 and LTA were labeled with antibody for flow cytometric analysis. Percent of TLR2 + beads that were FITC-LTA + is shown. Mean (n=3 replicates) ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 (ANOVA with Dunnett’s post hoc test).

    Article Snippet: Similarly, to assess KAMPs binding to TLR2, TLR2-conjugated beads preincubated with individual KAMP at the aforementioned concentrations were washed with PBS, then incubated with S. aureus LTA (1 μg/ml) (Sigma-Aldrich) and recombinant human CD14 (R&D) (0.1 μM) for 1 h. To assess the effect of KAMPs on CD14-LTA interaction, KAMPs (0.1 μM equivalent to 78 ng/ml for KAMP-10 and SC-10; 160 ng/ml for KAMP-18C) were preincubated with equal molar of CD14 (0.1 μM) for 1 h on ice before incubation with TLR2-conjugated beads and LTA for 1 h. To detect LTA and TLR2 by flow cytometry, mouse monoclonal FITC anti-LTA antibody (clone 55; Novus Biologicals) and mouse recombinant PE anti-human/mouse TLR2 (clone QA16A01; Biolegend) were used.

    Techniques: Binding Assay, Incubation, Labeling, Flow Cytometry, Comparison

    Kidney histology and differential lectin staining. Formalin fixed, paraffin embedded 5 μm sections of kidney tissues from 6 week-old mice of the indicated genotypes were stained with H&E and examined by light microscopy ( A-F ) or stained with lectins LTA (green, proximal tubules) and DBA (red, distal tubules) and examined by immunofluorescence microscopy ( G,H,I ). Panels A-C are 5X magnification with scale bars equal to 100 μm. Boxed areas are shown at 40X magnification in corresponding panels D-F with scale bars equal to 20 μm. Lectin staining was performed on serial sections corresponding to H&E stained samples. Cell nuclei were stained with DAPI. Scale bars in panels G-I are equal to 10 μm. The asterisk (*) identifies a large cyst that was not stained by either LTA or DBA. Images are representative of tissue sections from 3 animals.

    Journal: bioRxiv

    Article Title: Cystin gene mutations cause autosomal recessive polycystic kidney disease associated with altered Myc expression

    doi: 10.1101/2020.02.18.946285

    Figure Lengend Snippet: Kidney histology and differential lectin staining. Formalin fixed, paraffin embedded 5 μm sections of kidney tissues from 6 week-old mice of the indicated genotypes were stained with H&E and examined by light microscopy ( A-F ) or stained with lectins LTA (green, proximal tubules) and DBA (red, distal tubules) and examined by immunofluorescence microscopy ( G,H,I ). Panels A-C are 5X magnification with scale bars equal to 100 μm. Boxed areas are shown at 40X magnification in corresponding panels D-F with scale bars equal to 20 μm. Lectin staining was performed on serial sections corresponding to H&E stained samples. Cell nuclei were stained with DAPI. Scale bars in panels G-I are equal to 10 μm. The asterisk (*) identifies a large cyst that was not stained by either LTA or DBA. Images are representative of tissue sections from 3 animals.

    Article Snippet: Lectins LTA-FITC (# W0909) and DBA-Rhodamine (# Y0828) were obtained from Vector Laboratories.

    Techniques: Staining, Formalin-fixed Paraffin-Embedded, Light Microscopy, Immunofluorescence, Microscopy